| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 271,105 | 255,981 | 295,509 | 321,056 | | Cost of Revenue | 211,921 | 205,495 | 216,664 | 243,920 | | | Gross Profit | 59,184 | 50,486 | 78,845 | 77,136 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 37,937 | 37,990 | 38,930 | 42,560 | | Non Recurring |
-
|
-
| (1,694) | 43,175 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,247 | 12,496 | 41,609 | (8,599) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 223 | (118) | 163 | 140 | | Earnings Before Interest And Taxes | 21,470 | 12,378 | 41,772 | (8,459) | | Interest Expense | 5,423 | 5,505 | 6,441 | 8,105 | | Income Before Tax | 16,047 | 6,873 | 35,331 | (16,564) | | Income Tax Expense | 6,602 | 2,679 | 12,881 | (5,115) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,445 | 4,194 | 22,450 | (11,449) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,445 | 4,194 | 22,450 | (11,449) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,445 | $4,194 | $22,450 | ($11,449) |
|
0.67% Nasdaq 0.00%
Income Statement
